0.90p+0.05 (+5.88%)26 Apr 2024, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Aptamer Group PLC Market & Company News

25.04.2024 15:45APTAHolding(s) in CompanyRNS
24.04.2024 08:45APTAHolding(s) in CompanyRNS
23.04.2024 14:03APTAHolding(s) in Company - REPLACEMENTRNS
22.04.2024 20:03TPOU, MHN, CCLEARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savingsAlliance
22.04.2024 16:37APTAHolding(s) in CompanyRNS
22.04.2024 07:00APTATop Pharma Company evaluates Optimer for medicineRNS
18.04.2024 11:54APTAAptamer inks new Optimer+ transplant rejection therapy partnershipAlliance
18.04.2024 10:06APTATR-1: Notification of major holdingsRNS
18.04.2024 07:00APTAAptamer and Kairos Biotech partner for Optimer+RNS
08.04.2024 14:27ULVR, APTAAptamer submits patent application for Optimer bindersAlliance
08.04.2024 07:00APTAPatent submission for Optimer® bindersRNS
28.03.2024 14:07APTAHolding(s) in CompanyRNS
28.03.2024 12:29ARBB, APTA, GSCEARNINGS AND TRADING: Arbuthnot ups payout as profit more than doublesAlliance
28.03.2024 07:00APTAInterim ResultsRNS
22.03.2024 07:00APTANotice of Interim Results & Investor PresentationRNS
14.03.2024 07:00APTAInvestor WebinarReach
11.03.2024 11:08APTA, ULVRAptamer shares jump on successful Unilever contract progressionAlliance
11.03.2024 07:00APTAAptamer Progresses Partnership with UnileverRNS
29.02.2024 07:00APTABlock Listing Interim ReviewRNS
27.02.2024 14:27APTAAptamer says new Optimer+ delivers improved resultsAlliance
27.02.2024 07:00APTAR&D progress on new Optimer®+ platformRNS
22.02.2024 13:21APTAAptamer and Neuro-Bio begin Alzheimer's test development second phaseAlliance
22.02.2024 07:00APTASecond Phase of Alzheimer's test with Neuro-BioRNS
05.02.2024 11:25APTAAptamer shares plunge as half-year revenue to fall by 70%Alliance
05.02.2024 07:00APTAHalf Year Trading UpdateRNS
04.01.2024 14:39APTAHolding(s) in CompanyRNS
15.12.2023 15:57APTAResults of 2023 Annual General MeetingRNS
15.12.2023 07:00APTAAGM StatementRNS
14.12.2023 14:25APTAIN BRIEF: Aptamer inks deal for Optimer discovery with biotech firmAlliance
14.12.2023 07:00APTAMaterial Agreement with Genetic Medicines CompanyRNS
08.12.2023 14:54ULTP, SREI, RENXUK shareholder meetings calendar - next 7 daysAlliance
20.11.2023 07:00APTAPosting of Annual Report and Notice of AGMRNS
09.11.2023 18:11RGL, SOUC, APTAEARNINGS AND TRADING: Aptamer revenue falls, loss widensAlliance
09.11.2023 07:00APTAFull year results for the 12mths ended 30 Jun 2023RNS
08.11.2023 12:20APTANotice of Results and Investor PresentationRNS
06.11.2023 10:59APTAAptamer says interim revenue to fall due to weak customer confidenceAlliance
06.11.2023 10:24APTA, POS, STGAIM WINNERS & LOSERS: Strip Tinning and Plexus win dealsAlliance
06.11.2023 07:00APTATrading UpdateRNS
24.10.2023 10:16APTAHolding(s) in CompanyRNS
09.10.2023 09:40APTAGrant of Options and Related Party TransactionRNS
19.09.2023 21:57APTAIN BRIEF: Aptamer raises GBP310,772 through subscription and placingAlliance
19.09.2023 14:35APTAPlacing and Subscription, PDMR Dealing and TVRRNS
13.09.2023 12:58APTAHolding(s) in CompanyRNS
31.08.2023 07:00APTAHolding(s) in CompanyRNS
24.08.2023 18:09APTAHolding(s) in CompanyRNS
24.08.2023 18:05APTAHolding(s) in CompanyRNS
21.08.2023 13:20APTAHolding(s) in CompanyRNS
21.08.2023 13:17APTAHolding(s) in CompanyRNS
17.08.2023 16:48APTAUPDATE: Aptamer launches cost-cutting blitz as it targets break-evenAlliance
17.08.2023 12:47APTAResult of General MeetingRNS
17.08.2023 09:30APTAAptamer hails contracts with "top five pharma partner"Alliance
17.08.2023 07:00APTAContract winsRNS
15.08.2023 17:43APTATR-1RNS
15.08.2023 17:40APTATR-1RNS
31.07.2023 10:46SCLP, TYM, APTAAIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trialAlliance
31.07.2023 10:18APTAAptamer terminates sales process after fundraise; CEO and CFO resignAlliance
31.07.2023 09:04APTAForm 8.5 (EPT/RI)RNS
31.07.2023 07:01APTAUpdate on Strategic Review and Formal Sale ProcessRNS
31.07.2023 07:00APTAFundraise, Proposed Board Changes, RPT, GM NoticeRNS
28.07.2023 08:57APTAForm 8.5 (EPT/RI)RNS
27.07.2023 09:36APTAForm 8.5 (EPT/RI) - Aptamer Group PLCRNS
26.07.2023 21:46TRAF, APTA, TRACTRADING UPDATES: Van Elle profit rises; Costain financing pactAlliance
26.07.2023 10:57APTAResponse to Speculation, Strategic Review, UpdateRNS
07.07.2023 10:37HE1, QED, APTAAIM WINNERS & LOSERS: Aptamer shares claw back some lost groundAlliance
07.07.2023 09:28APTAAptamer shares surge on signing of four new contracts worth GBP507,000Alliance
07.07.2023 07:00APTAContract WinsRNS
04.07.2023 10:32APTA, RST, ALBAAIM WINNERS & LOSERS: Alba wins permits; Aptamer cash-strappedAlliance
04.07.2023 09:31APTAAptamer shares plummet as revenue falls, recquires further fundingAlliance
04.07.2023 07:00APTATrading UpdateRNS
14.06.2023 13:41APTAIN BRIEF: Aptamer notes share jump, not aware of reason for riseAlliance
14.06.2023 12:16APTAResponse to Share Price MovementRNS
14.06.2023 09:50SLE, GCM, APTAAIM WINNERS & LOSERS: Aptamer soars on Alzheimer's test successAlliance
14.06.2023 09:25APTAAptamer shares soar after success in rapid Alzheimer test developmentAlliance
14.06.2023 07:00APTAAptamer & Neuro-Bio to develop Alzheimer’s testReach
10.05.2023 12:08APTAIN BRIEF: Aptamer CEO Arron Tolley resigns with immediate effectAlliance
Showing 1 to 75 of 134